SCNX
Scienture Holdings, Inc.NASDAQHEALTHCAREPHARMACEUTICAL RETAILERS
Key Statistics
Market Cap
$16.33M
P/E Ratio
—
EPS
$-2.45
Beta
—
52W High
$2.60
52W Low
$0.24
50-Day MA
$0.40
200-Day MA
$0.65
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
21.83
PEG Ratio
—
About Scienture Holdings, Inc.
Scienture Holdings, Inc. (SCNX) is a biotechnology firm focused on developing advanced therapeutic solutions for neurological disorders, utilizing an innovative drug development pipeline backed by a skilled research team. With a strong emphasis on addressing unmet medical needs, Scienture is poised to enhance patient outcomes while navigating the complexities of regulatory pathways. The company’s dedication to scientific rigor and its strategic partnerships not only bolster its growth potential but also position SCNX as a significant contributor to advancements in global healthcare. As the demand for effective neurological treatments grows, Scienture aims to leverage emerging opportunities within the expanding healthcare landscape.
Fundamentals
| Revenue (TTM) | 477,680 |
| Gross Profit (TTM) | 384,660 |
| EBITDA | $-15.27M |
| Operating Margin | -6231.00% |
| Return on Equity | -56.60% |
| Return on Assets | -10.80% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $1.73 |
| Price-to-Book | 0.24 |
| Price-to-Sales (TTM) | 34.19 |
| EV/Revenue | 26.8 |
| EV/EBITDA | -1.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 449.10% |
| Shares Outstanding | $40.63M |
| Float | $32.79M |
| % Insiders | 13.31% |
| % Institutions | 3.87% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026